Vagefi Parsia A, Parekh Justin, Ascher Nancy L, Roberts John P, Freise Chris E
Division of Transplant Surgery, Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA.
Arch Surg. 2011 Sep;146(9):1052-9. doi: 10.1001/archsurg.2011.218.
Split liver transplantation (SLT) allows for expansion of the deceased donor pool.
To assess outcomes and the impact of splitting technique (in situ vs ex vivo) in SLT recipients.
Single-center retrospective review (September 18, 1993, to July 1, 2010).
University medical center.
One hundred six SLT recipients.
Postoperative graft and patient survival and postoperative complications.
In adults, 1-, 5-, and 10-year overall patient survival was 93%, 77%, and 73%, respectively; overall graft survival was 89%, 76%, and 65%, respectively; ex vivo split patient survival was 93%, 85%, and 74%, respectively; and ex vivo graft survival was 86%, 77%, and 63%, respectively. In situ split patient and graft survival was 94% at 1 year and 75% at 5 years. Postoperative complications included biliary (29%), vascular (11%), unplanned reexploratory surgery (11%), incisional hernia (8%), small-for-size syndrome (n = 1), need for shunt at the time of SLT (n = 1), and primary nonfunction (n = 1). In children, 1-, 5-, and 10-year overall patient survival was 84%, 75%, and 69%, respectively; overall graft survival was 77%, 63%, and 57%, respectively; ex vivo split patient survival was 83%, 73%, and 73%, respectively; and ex vivo graft survival was 75%, 59%, and 59%, respectively. In situ split patient and graft survival was 86% at 1 and 5 years. Postoperative complications included biliary (40%), vascular (26%), and primary nonfunction (n = 1).
Split liver transplantation remains an excellent option for expansion of the deceased donor pool for adult and pediatric populations. Postoperative morbidity remains high; however, this is justifiable owing to limited resources.
活体肝移植(SLT)可扩大脑死亡供体库。
评估活体肝移植受者的预后以及分割技术(原位分割与体外分割)的影响。
单中心回顾性研究(1993年9月18日至2010年7月1日)。
大学医学中心。
106例活体肝移植受者。
术后移植物和患者生存率以及术后并发症。
在成人中,1年、5年和10年的总体患者生存率分别为93%、77%和73%;总体移植物生存率分别为89%、76%和65%;体外分割患者生存率分别为93%、85%和74%;体外分割移植物生存率分别为86%、77%和63%。原位分割患者和移植物1年生存率为94%,5年生存率为75%。术后并发症包括胆系并发症(29%)、血管并发症(11%)、计划外再次手术(11%)、切口疝(8%)、小肝综合征(1例)、活体肝移植时需要分流术(1例)和原发性无功能(1例)。在儿童中,1年、5年和10年的总体患者生存率分别为84%、75%和69%;总体移植物生存率分别为77%、63%和57%;体外分割患者生存率分别为83%、73%和73%;体外分割移植物生存率分别为75%、59%和59%。原位分割患者和移植物1年和5年生存率为86%。术后并发症包括胆系并发症(40%)、血管并发症(26%)和原发性无功能(1例)。
活体肝移植仍然是扩大成人和儿童脑死亡供体库的极佳选择。术后发病率仍然很高;然而,由于资源有限,这是合理的。